These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1718397)

  • 1. Efficacy of disopyramide and mexiletine used alone or in combination in the treatment of ventricular premature beats.
    Sakurada H; Motomiya T; Hiraoka M
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():835-41. PubMed ID: 1718397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
    Tanabe T; Takahashi K; Yoshioka K; Goto Y
    Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
    Kim SG; Mercando AD; Tam S; Fisher JD
    J Am Coll Cardiol; 1989 Mar; 13(3):659-64. PubMed ID: 2918173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
    Tanabe T
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():827-34. PubMed ID: 1931759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
    Breithardt G; Seipel L; Abendroth RR
    J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mexiletine and disopyramide suppress ventricular premature contractions (VPC) irrespective of the relationship between the VPC and the underlying heart rate.
    Saikawa T; Nakagawa M; Takahashi N; Ishida S; Fujino T; Ito M; Shimoyama N; Hara M; Yonemochi H; Maeda T
    Jpn Heart J; 1992 Sep; 33(5):665-78. PubMed ID: 1283888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the combination of low-dose mexiletine and metoprolol on ventricular arrhythmia.
    Ravid S; Lampert S; Graboys TB
    Clin Cardiol; 1991 Dec; 14(12):951-5. PubMed ID: 1726725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a combination of disopyramide and mexiletine on the anterograde accessory pathway conduction in patients with Wolff-Parkinson-White syndrome.
    Shimizu W; Ohe T; Kurita T; Takaki H; Aihara N; Kamakura S; Matsuhisa M; Shimomura K
    Eur Heart J; 1992 Feb; 13(2):261-8. PubMed ID: 1555626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of combination therapy with mexiletine and a low dose of propranolol for premature ventricular arrhythmias.
    Kobayashi A; Yamazaki N; Kobayashi T; Watanabe T; Ito T; Ogawa K
    Jpn Circ J; 1990 Dec; 54(12):1486-96. PubMed ID: 2077145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oral mexiletine therapy at a 12-h dosage interval.
    Steen SN; Hughes EM; Sharon G; MacGregor TR
    Chest; 1990 Feb; 97(2):358-63. PubMed ID: 1688758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
    Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ
    Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
    Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-arrhythmic efficacy of perhexiline maleate, disopyramide and mexiletine in ventricular ectopic activity.
    Myburgh DP; Goldman AP
    S Afr Med J; 1978 Dec; 54(25):1053-5. PubMed ID: 371028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potentiation of an anti-arrhythmia action by the combined use of mexiletine and propranolol].
    Pacholke H; Beck OA; Hochrein H
    Dtsch Med Wochenschr; 1984 Mar; 109(9):330-4. PubMed ID: 6199177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of mexiletine in the medium-term treatment of ventricular arrhythmias. A randomized, double-blind, crossover trial against placebo in ambulatory patients.
    Masotti G; Morettini A; Casolo GC; Ieri A; Zipoli A; Serneri GG
    J Int Med Res; 1984; 12(2):73-80. PubMed ID: 6202571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
    Capucci A; Di Pasquale G; Boriani G; Carini G; Balducelli M; Frabetti L; Carozzi A; Finzi A; Pinelli G; Magnani B
    Int J Clin Pharmacol Res; 1991; 11(1):23-33. PubMed ID: 1714885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study.
    Caron JF; Libersa CC; Kher AR; Kacet S; Wanszelbaum H; Dupuis BA; Poirier JM; Lekieffre JP
    J Am Coll Cardiol; 1985 Jun; 5(6):1457-63. PubMed ID: 2582017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation].
    Breithardt G; Haerten K; Seipel L
    Z Kardiol; 1976 Aug; 65(8):713-23. PubMed ID: 61664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
    Wagner WL; Manz M; Lüderitz B
    Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
    Aizawa Y; Chinushi M; Naitoh N; Shibata A
    Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.